BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10961174)

  • 1. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
    Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
    J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
    Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
    Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
    Pillai V; Cibas ES; Dorfman DM
    Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
    Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
    Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
    Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
    Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of carcinoma metastasis by flow cytometry: A study of 238 cases.
    Acosta M; Pereira J; Arroz M
    Cytometry B Clin Cytom; 2016 May; 90(3):289-94. PubMed ID: 26054018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls.
    Dong HP; Holth A; Berner A; Davidson B; Risberg B
    Cytometry B Clin Cytom; 2007 Sep; 72(5):332-43. PubMed ID: 17226863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.
    Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P
    Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
    De Angelis M; Buley ID; Heryet A; Gray W
    Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
    Maguire B; Whitaker D; Carrello S; Spagnolo D
    Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA.
    Stoop JA; Hendriks JG; Berends D
    Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
    Sayed DM; el-Attar MM; Hussein AA
    Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
    Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry.
    Queiroz C; Barral-Netto M; Bacchi CE
    Acta Cytol; 2001; 45(1):18-22. PubMed ID: 11213499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
    He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
    World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.
    Arora R; Agarwal S; Mathur SR; Verma K; Iyer VK; Aron M
    Cytojournal; 2011; 8():14. PubMed ID: 21829416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.